HCMT
NERV icon

Highland Capital Management (Texas)’s Minerva Neurosciences NERV Stock Holding History

Highland Capital Management (Texas)’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,197,563
Closed -$608M – 328
2015
Q1 		$608M Buy
+15,197,563
New +$629M 12.49% 1

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return

Highland Capital Management (Texas)'s NERV Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Minerva Neurosciences (NERV) position steady in Q2 2019 at 107,715 shares worth $4.85M. The position accounts for 0.28% of the portfolio, ranked #61.

Highland Capital Management (Texas) first reported a position in NERV in Q3 2014 and has held it in 18 quarters since. The position peaked at $19.8M in Q1 2017. 85 funds tracked by Wall St. Rank hold NERV as of Q2 2019.

  • Highland Capital Management (Texas) held 107,715 shares of Minerva Neurosciences worth $4.85M as of Q2 2019.
  • Highland Capital Management (Texas) left its Minerva Neurosciences share count unchanged in Q2 2019.
  • Minerva Neurosciences made up 0.28% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #61 holding.
  • Highland Capital Management (Texas) first reported a position in Minerva Neurosciences in Q3 2014 and has held it in 18 quarters since.
  • Highland Capital Management (Texas)'s Minerva Neurosciences position peaked at $19.8M in Q1 2017.
  • 85 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.